The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine…
View More Interim recommendations for use of recombinant COVID-19 vaccine updated to reflect latest evidence
Home »
Third COVID-19 vaccine dose may prompt response in transplant recipients
(HealthDay)—A third dose of the mRNA-1273 vaccine induces a serologic response in 49 percent of…
View More Third COVID-19 vaccine dose may prompt response in transplant recipients
Vaccinated Officials in US, UK Test Positive for COVID-19
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Multiple…
View More Vaccinated Officials in US, UK Test Positive for COVID-19
Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection
Malaria is a life-threatening mosquito-borne disease that is caused by one of four parasites including…
View More Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection
COVID vaccine from Germanys CureVac just 48% effective
Germany’s CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy…
View More COVID vaccine from Germanys CureVac just 48% effective
COVID Vaccine Study Drew Scrutiny and Expression of Concern
A study published last week that quickly became another flashpoint for those arguing that COVID-19…
View More COVID Vaccine Study Drew Scrutiny and Expression of Concern
Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says
FDA to hold emergency meeting on COVID vaccine side effects in adolescents New York Medical…
View More Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says
Back-to-School Threat: Missed Vaccinations in Children, Teens
US children and adolescents may be at higher risk for vaccine-preventable diseases this fall as…
View More Back-to-School Threat: Missed Vaccinations in Children, Teens
New article explains the pros and cons of nasal vaccines
Vaccines are mostly synonymous with needles, an efficient and effective way to provide immunity to…
View More New article explains the pros and cons of nasal vaccines
Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants
In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from…
View More Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants